Kind, the maker of the popular nut bars, filed a petition Wednesday asking the FDA to change how it regulates claims on food labels.
Kind, the maker of the popular nut bars, filed a petition Wednesday asking the Food and Drug Administration to change how it regulates claims on food labels.
This isn't the first time that Kind has filed a petition for the agency to reconsider how it regulates food labeling. Back in 2015, the FDA requested that Kind stop using"healthy" on its website and several of its wrappers because those products exceeded the maximum amount of total fat or saturated fat allowed to make that claim.
Now a few years later and with an investment from Snickers-owner Mars under its belt, Kind is asking the FDA to implement more sweeping changes. It wants the agency to update the rules regulating what brands can tout on their wrapper like"good source of calcium" or"low sodium," known in the industry as nutrient content claims.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Consulte Mais informação »
Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDAScott Gottlieb, possibly Trump's only effective regulator, announces his departure from the FDA — but what will come of his initiatives? hiltzikm weighs in:
Consulte Mais informação »
For persistent depression, FDA approves a novel treatment based on ketamineFor people with intractable depression, the FDA has approved a nasal spray called esketamine, which can take effect in hours, compared to weeks or months for traditional treatments. Esketamine is a component of ketamine, which has been used as a party drug.
Consulte Mais informação »
FDA finds asbestos in makeup at Claire'sThe U.S. Food and Drug Administration on Tuesday warned consumers not to use certain cosmetic products sold by Claire's after they were found to contain asbestos, a known carcinogen. Samples of Claire's eye shadows batch no./lot no. 08/17, compact powder batch no./lot no. 07/15 and contour palette
Consulte Mais informação »
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Consulte Mais informação »
FDA chief Gottlieb resigns as agency battles teen vaping, opioid crisisFDA Commissioner Scott Gottlieb announced his resignation yesterday after having launched an aggressive campaign against teen smoking and the opioid crisis during his time in the post. The announcement came as a surprise to many.
Consulte Mais informação »
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
Consulte Mais informação »
FDA allows treatment of depression with club drug's cousinWASHINGTON (AP) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness.
Consulte Mais informação »
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Consulte Mais informação »